Detalhe da pesquisa
1.
Diminished seroconversion following a single SARS-COV-2 vaccine in ocrelizumab-treated relapsing-remitting multiple sclerosis patients.
Mult Scler
; 28(7): 1126-1130, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34595965